-+ 0.00%
-+ 0.00%
-+ 0.00%

Daiwa Capital Upgrades Merck & Co to Outperform, Raises Price Target to $143

Benzinga·08/12/2026 15:48:47
Listen to the news
Daiwa Capital analyst Narumi Nakagiri upgrades Merck & Co (NYSE:MRK) from Neutral to Outperform and raises the price target from $120 to $143.